# Carlisle Companies Inc: financial statements, quarterly

CSL · NYSE · CIK 790051 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/csl.md) · [Financials](/companies/csl/financials.md) · [Filings](/companies/csl/filings.md) · [Insiders](/companies/csl/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/csl/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,128](/filings/0000790051-24-000058.md) | [1,097](/filings/0000790051-25-000097.md) | [1,451](/filings/0000790051-25-000146.md) | [1,334](/filings/0000790051-25-000159.md) | [1,123 d](/filings/0000790051-26-000012.md) | [1,096](/filings/0000790051-26-000017.md) | [1,450](/filings/0000790051-26-000037.md) | [1,347](/filings/0000790051-26-000053.md) | [1,128 d](/filings/0000790051-26-000012.md) | [1,052](/filings/0000790051-26-000017.md) | [1,570](/filings/0000790051-26-000037.md) | [1,463](/filings/0000790051-26-000053.md) |
| Cost of revenue | $m | [708 d](/filings/0000790051-26-000012.md) | [698](/filings/0000790051-25-000097.md) | [882](/filings/0000790051-25-000146.md) | [819](/filings/0000790051-25-000159.md) | [717 d](/filings/0000790051-26-000012.md) | [710](/filings/0000790051-26-000017.md) | [908](/filings/0000790051-26-000037.md) | [862](/filings/0000790051-26-000053.md) | [747 d](/filings/0000790051-26-000012.md) | [689](/filings/0000790051-26-000017.md) | [1,002](/filings/0000790051-26-000037.md) | [969](/filings/0000790051-26-000053.md) |
| Gross profit | $m | [420](/filings/0000790051-24-000058.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $m | [8.0 d](/filings/0000790051-26-000012.md) | [9.2](/filings/0000790051-25-000097.md) | [9.3](/filings/0000790051-25-000146.md) | [8.1](/filings/0000790051-25-000159.md) | [8.8 d](/filings/0000790051-26-000012.md) | [10.7](/filings/0000790051-26-000017.md) | [11.1](/filings/0000790051-26-000037.md) | [12.4](/filings/0000790051-26-000053.md) | [12.9 d](/filings/0000790051-26-000012.md) | [12.1](/filings/0000790051-26-000017.md) | [11.4](/filings/0000790051-26-000037.md) | [11.9](/filings/0000790051-26-000053.md) |
| Selling, general and administrative | $m | [158 d](/filings/0000790051-26-000012.md) | [167](/filings/0000790051-25-000097.md) | [189](/filings/0000790051-25-000146.md) | [192](/filings/0000790051-25-000159.md) | [175 d](/filings/0000790051-26-000012.md) | [194](/filings/0000790051-26-000017.md) | [197](/filings/0000790051-26-000037.md) | [178](/filings/0000790051-26-000053.md) | [177 d](/filings/0000790051-26-000012.md) | [172](/filings/0000790051-26-000017.md) | [199](/filings/0000790051-26-000037.md) | [186](/filings/0000790051-26-000053.md) |
| Operating income | $m | [254](/filings/0000790051-24-000058.md) | [225](/filings/0000790051-25-000097.md) | [378](/filings/0000790051-25-000146.md) | [316](/filings/0000790051-25-000159.md) | [224 d](/filings/0000790051-26-000012.md) | [184](/filings/0000790051-26-000017.md) | [335](/filings/0000790051-26-000037.md) | [294](/filings/0000790051-26-000053.md) | [190 d](/filings/0000790051-26-000012.md) | [180](/filings/0000790051-26-000017.md) | [353](/filings/0000790051-26-000037.md) | [293](/filings/0000790051-26-000053.md) |
| Interest expense | $m | [18.6 d](/filings/0000790051-26-000012.md) | [18.6](/filings/0000790051-25-000097.md) | [18.8](/filings/0000790051-25-000146.md) | [18.6](/filings/0000790051-25-000159.md) | [17.3 d](/filings/0000790051-26-000012.md) | [14.8](/filings/0000790051-26-000017.md) | [14.7](/filings/0000790051-26-000037.md) | [21.3](/filings/0000790051-26-000053.md) | [27.7 d](/filings/0000790051-26-000012.md) | [28.3](/filings/0000790051-26-000017.md) | [27.4](/filings/0000790051-26-000037.md) | [27.7](/filings/0000790051-26-000053.md) |
| Income tax | $m | [52.8 d](/filings/0000790051-26-000012.md) | [43.9](/filings/0000790051-25-000097.md) | [87.4](/filings/0000790051-25-000146.md) | [74.9](/filings/0000790051-25-000159.md) | [39.6 d](/filings/0000790051-26-000012.md) | [34.9](/filings/0000790051-26-000017.md) | [68.1](/filings/0000790051-26-000037.md) | [64.3](/filings/0000790051-26-000053.md) | [39.0 d](/filings/0000790051-26-000012.md) | [35.5](/filings/0000790051-26-000017.md) | [76.0](/filings/0000790051-26-000037.md) | [62.5](/filings/0000790051-26-000053.md) |
| Net income | $m | [206](/filings/0000790051-24-000058.md) | [192](/filings/0000790051-25-000097.md) | [712](/filings/0000790051-25-000146.md) | [244](/filings/0000790051-25-000159.md) | [163 d](/filings/0000790051-26-000012.md) | [143](/filings/0000790051-26-000017.md) | [256](/filings/0000790051-26-000037.md) | [214](/filings/0000790051-26-000053.md) | [127 d](/filings/0000790051-26-000012.md) | [128](/filings/0000790051-26-000017.md) | [255](/filings/0000790051-26-000037.md) | [208](/filings/0000790051-26-000053.md) |
| Diluted EPS | $ per share | [4.20](/filings/0000790051-24-000058.md) | [3.97](/filings/0000790051-25-000097.md) | [14.84](/filings/0000790051-25-000146.md) | [5.25](/filings/0000790051-25-000159.md) | not reported | [3.20](/filings/0000790051-26-000017.md) | [5.88](/filings/0000790051-26-000037.md) | [4.98](/filings/0000790051-26-000053.md) | not reported | [3.10](/filings/0000790051-26-000017.md) | [6.30](/filings/0000790051-26-000037.md) | [5.24](/filings/0000790051-26-000053.md) |
| Basic EPS | $ per share | [4.25](/filings/0000790051-24-000058.md) | [4.02](/filings/0000790051-25-000097.md) | [15.03](/filings/0000790051-25-000146.md) | [5.31](/filings/0000790051-25-000159.md) | not reported | [3.23](/filings/0000790051-26-000017.md) | [5.93](/filings/0000790051-26-000037.md) | [5.02](/filings/0000790051-26-000053.md) | not reported | [3.12](/filings/0000790051-26-000017.md) | [6.33](/filings/0000790051-26-000037.md) | [5.27](/filings/0000790051-26-000053.md) |

- Revenue: us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [577](/filings/0000790051-25-000077.md) | [553](/filings/0000790051-24-000085.md) | [1,736](/filings/0000790051-24-000166.md) | [1,531](/filings/0000790051-24-000198.md) | [754](/filings/0000790051-26-000012.md) | [220](/filings/0000790051-25-000097.md) | [68.4](/filings/0000790051-25-000146.md) | [1,105](/filings/0000790051-25-000159.md) | [1,112](/filings/0000790051-26-000053.md) | [771](/filings/0000790051-26-000017.md) | [665](/filings/0000790051-26-000037.md) | [547](/filings/0000790051-26-000053.md) |
| Current assets | $m | [3,408](/filings/0000790051-25-000077.md) | [3,463](/filings/0000790051-24-000085.md) | [3,152](/filings/0000790051-24-000166.md) | [2,911](/filings/0000790051-24-000198.md) | [1,926](/filings/0000790051-26-000012.md) | [1,532](/filings/0000790051-25-000097.md) | [1,527](/filings/0000790051-25-000146.md) | [2,483](/filings/0000790051-25-000159.md) | [2,277](/filings/0000790051-26-000053.md) | [2,032](/filings/0000790051-26-000017.md) | [2,297](/filings/0000790051-26-000037.md) | [2,104](/filings/0000790051-26-000053.md) |
| Total assets | $m | [6,620](/filings/0000790051-25-000077.md) | [6,646](/filings/0000790051-24-000085.md) | [6,728](/filings/0000790051-24-000166.md) | [6,478](/filings/0000790051-24-000198.md) | [5,817](/filings/0000790051-26-000012.md) | [5,451](/filings/0000790051-25-000097.md) | [5,519](/filings/0000790051-25-000146.md) | [6,457](/filings/0000790051-25-000159.md) | [6,263](/filings/0000790051-26-000053.md) | [5,990](/filings/0000790051-26-000017.md) | [6,235](/filings/0000790051-26-000037.md) | [6,030](/filings/0000790051-26-000053.md) |
| Current liabilities | $m | [1,186](/filings/0000790051-25-000077.md) | [1,175](/filings/0000790051-24-000085.md) | [1,090](/filings/0000790051-24-000166.md) | [1,068](/filings/0000790051-24-000198.md) | [666](/filings/0000790051-26-000012.md) | [593](/filings/0000790051-25-000097.md) | [697](/filings/0000790051-25-000146.md) | [765](/filings/0000790051-25-000159.md) | [736](/filings/0000790051-26-000053.md) | [601](/filings/0000790051-26-000017.md) | [883](/filings/0000790051-26-000037.md) | [875](/filings/0000790051-26-000053.md) |
| Long-term debt | $m | [1,887](/filings/0000790051-25-000077.md) | [1,887](/filings/0000790051-24-000085.md) | [1,887](/filings/0000790051-24-000166.md) | [1,887](/filings/0000790051-24-000198.md) | [1,887](/filings/0000790051-26-000012.md) | [1,891](/filings/0000790051-25-000097.md) | [1,892](/filings/0000790051-25-000146.md) | [2,879](/filings/0000790051-25-000159.md) | [2,882](/filings/0000790051-26-000053.md) | [2,884](/filings/0000790051-26-000017.md) | [2,885](/filings/0000790051-26-000037.md) | [2,887](/filings/0000790051-26-000053.md) |
| Current portion of debt | $m | [403](/filings/0000790051-25-000077.md) | [403](/filings/0000790051-24-000085.md) | [403](/filings/0000790051-24-000166.md) | [403](/filings/0000790051-24-000198.md) | [3.2](/filings/0000790051-26-000012.md) | [3.9](/filings/0000790051-25-000097.md) | [4.3](/filings/0000790051-25-000146.md) | [4.5](/filings/0000790051-25-000159.md) | [4.8](/filings/0000790051-26-000053.md) | [4.9](/filings/0000790051-26-000017.md) | [5.0](/filings/0000790051-26-000037.md) | [5.3](/filings/0000790051-26-000053.md) |
| Shareholders' equity | $m | [2,829](/filings/0000790051-26-000012.md) | [2,859](/filings/0000790051-25-000146.md) | [3,004](/filings/0000790051-25-000159.md) | [2,763](/filings/0000790051-25-000159.md) | [2,463](/filings/0000790051-26-000053.md) | [2,167](/filings/0000790051-26-000037.md) | [2,121](/filings/0000790051-26-000053.md) | [1,992](/filings/0000790051-26-000053.md) | [1,795](/filings/0000790051-26-000053.md) | [1,653](/filings/0000790051-26-000037.md) | [1,617](/filings/0000790051-26-000053.md) | [1,438](/filings/0000790051-26-000053.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [389 d](/filings/0000790051-26-000012.md) | [164](/filings/0000790051-25-000097.md) | [183 d](/filings/0000790051-25-000146.md) | [313 d](/filings/0000790051-25-000159.md) | [371 d](/filings/0000790051-26-000012.md) | [1.8](/filings/0000790051-26-000017.md) | [287 d](/filings/0000790051-26-000037.md) | [427 d](/filings/0000790051-26-000053.md) | [386 d](/filings/0000790051-26-000012.md) | [(44.7)](/filings/0000790051-26-000017.md) | [242 d](/filings/0000790051-26-000037.md) | [314 d](/filings/0000790051-26-000053.md) |
| Capital expenditure | $m | [35.9 d](/filings/0000790051-26-000012.md) | [32.5](/filings/0000790051-25-000097.md) | [24.9 d](/filings/0000790051-25-000146.md) | [19.3 d](/filings/0000790051-25-000159.md) | [36.6 d](/filings/0000790051-26-000012.md) | [29.0](/filings/0000790051-26-000017.md) | [28.8 d](/filings/0000790051-26-000037.md) | [33.5 d](/filings/0000790051-26-000053.md) | [39.9 d](/filings/0000790051-26-000012.md) | [28.3](/filings/0000790051-26-000017.md) | [41.7 d](/filings/0000790051-26-000037.md) | [36.8 d](/filings/0000790051-26-000053.md) |
| Dividends paid | $m | [41.0 d](/filings/0000790051-26-000012.md) | [41.5](/filings/0000790051-25-000097.md) | [40.2 d](/filings/0000790051-25-000146.md) | [45.7 d](/filings/0000790051-25-000159.md) | [45.0 d](/filings/0000790051-26-000012.md) | [45.2](/filings/0000790051-26-000017.md) | [43.1 d](/filings/0000790051-26-000037.md) | [47.0 d](/filings/0000790051-26-000053.md) | [45.8 d](/filings/0000790051-26-000012.md) | [45.7](/filings/0000790051-26-000017.md) | [44.4 d](/filings/0000790051-26-000037.md) | [49.5 d](/filings/0000790051-26-000053.md) |
| Share repurchases | $m | [320 d](/filings/0000790051-26-000012.md) | [150](/filings/0000790051-25-000097.md) | [550 d](/filings/0000790051-25-000146.md) | [466 d](/filings/0000790051-25-000159.md) | [420 d](/filings/0000790051-26-000012.md) | [400](/filings/0000790051-26-000017.md) | [300 d](/filings/0000790051-26-000037.md) | [300 d](/filings/0000790051-26-000053.md) | [300 d](/filings/0000790051-26-000012.md) | [250](/filings/0000790051-26-000017.md) | [250 d](/filings/0000790051-26-000037.md) | [350 d](/filings/0000790051-26-000053.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [51.7](/filings/0000790051-24-000085.md) | [51.2](/filings/0000790051-24-000166.md) | [50.1](/filings/0000790051-24-000198.md) | [48.4](/filings/0000790051-25-000097.md) | [47.9](/filings/0000790051-25-000146.md) | [46.5](/filings/0000790051-25-000159.md) | [44.7](/filings/0000790051-26-000017.md) | [43.4](/filings/0000790051-26-000037.md) | [42.9](/filings/0000790051-26-000053.md) | [41.1](/filings/0000790051-26-000017.md) | [40.5](/filings/0000790051-26-000037.md) | [39.6](/filings/0000790051-26-000053.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 38,647,658 at 2026-10-22, from the cover of the [10-Q filed 2026-10-29](/filings/0000790051-26-000053.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 16:20 ET. No prices; not investment advice.